Characterization of AZD4694, a novel fluorinated Abeta plaque neuroimaging PET radioligand.

作者: Anders Juréus , Britt-Marie Swahn , Johan Sandell , Fredrik Jeppsson , Allan E. Johnson

DOI: 10.1111/J.1471-4159.2010.06812.X

关键词: Positron emission tomographyAlzheimer's diseasePathologyPositronNeuroimagingAmyloidRadioligandMedicine

摘要: Positron emission tomography (PET) radioligands that bind selectively to β-amyloid plaques (Aβ) are promising imaging tools aimed at supporting the diagnosis of Alzheimer’s disease and evaluati ...

参考文章(32)
D. S. Knopman, J. E. Parisi, A. Salviati, M. Floriach-Robert, B. F. Boeve, R. J. Ivnik, G. E. Smith, D. W. Dickson, K. A. Johnson, L. E. Petersen, W. C. McDonald, H. Braak, R. C. Petersen, Neuropathology of cognitively normal elderly. Journal of Neuropathology and Experimental Neurology. ,vol. 62, pp. 1087- 1095 ,(2003) , 10.1093/JNEN/62.11.1087
Peter T. Nelson, Heiko Braak, William R. Markesbery, Neuropathology and Cognitive Impairment in Alzheimer Disease: A Complex but Coherent Relationship Journal of Neuropathology and Experimental Neurology. ,vol. 68, pp. 1- 14 ,(2009) , 10.1097/NEN.0B013E3181919A48
Allan E. Johnson, Fredrik Jeppsson, Johan Sandell, David Wensbo, Jan A. M. Neelissen, Anders Juréus, Peter Ström, Henrietta Norman, Lars Farde, Samuel P. S. Svensson, AZD2184: a radioligand for sensitive detection of β‐amyloid deposits Journal of Neurochemistry. ,vol. 108, pp. 1177- 1186 ,(2009) , 10.1111/J.1471-4159.2008.05861.X
Reisa A. Sperling, Peter S. LaViolette, Kelly O'Keefe, Jacqueline O'Brien, Dorene M. Rentz, Maija Pihlajamaki, Gad Marshall, Bradley T. Hyman, Dennis J. Selkoe, Trey Hedden, Randy L. Buckner, J. Alex Becker, Keith A. Johnson, Amyloid deposition is associated with impaired default network function in older persons without dementia Neuron. ,vol. 63, pp. 178- 188 ,(2009) , 10.1016/J.NEURON.2009.07.003
Franco Lombardo, Marina Y. Shalaeva, Karl A. Tupper, Feng Gao, Elogdoct: a tool for lipophilicity determination in drug discovery basic and neutral compounds Journal of Medicinal Chemistry. ,vol. 44, pp. 2490- 2497 ,(2002) , 10.1021/JM0100990
Rebecca F. Rosen, Lary C. Walker, Harry LeVine, PIB binding in aged primate brain: Enrichment of high-affinity sites in humans with Alzheimer's disease Neurobiology of Aging. ,vol. 32, pp. 223- 234 ,(2011) , 10.1016/J.NEUROBIOLAGING.2009.02.011
William E Klunk, Chester A Mathis, The future of amyloid-beta imaging: a tale of radionuclides and tracer proliferation Current Opinion in Neurology. ,vol. 21, pp. 683- 687 ,(2008) , 10.1097/WCO.0B013E3283168E1A
A. Lockhart, J.R. Lamb, T. Osredkar, L.I. Sue, J.N. Joyce, L. Ye, V. Libri, D. Leppert, T.G. Beach, PIB is a non-specific imaging marker of amyloid-beta (Aβ) peptide-related cerebral amyloidosis Brain. ,vol. 130, pp. 2607- 2615 ,(2007) , 10.1093/BRAIN/AWM191
John C. Morris, Catherine M. Roe, Elizabeth A. Grant, Denise Head, Martha Storandt, Alison M. Goate, Anne M. Fagan, David M. Holtzman, Mark A. Mintun, Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease. JAMA Neurology. ,vol. 66, pp. 1469- 1475 ,(2009) , 10.1001/ARCHNEUROL.2009.269